(Q24235482)

5

0 references

Anne Littlewood

object named as

Anne Littlewood

6

0 references

Jan Clarkson

2

object named as

Jan E Clarkson

0 references

author name string

Gemma Bryan

3

0 references

Susan Furness

4

0 references

Martin G McCabe

7

0 references

Stefan Meyer

8

0 references

Tasneem Khalid

Cochrane Database of Systematic Reviews

9

0 references

publication date

8 December 2010

0 references

published in

0 references

cites work

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Sucralfate in the prevention of radiation-induced oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of Yangyin Humo Decoction on oral mucomembranous reaction to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of oral glutamine supplementation during bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucosi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

[Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The use of recombinant human granulocyte colony-stimulating factor in combination with single or fractionated doses of ifosfamide and doxorubicin in patients with advanced soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Fluorouracil and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Management of mucositis in oral irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Use of therapeutic laser for prevention and treatment of oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Relief of radiation-induced oral mucositis in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Palliation of radiation-related mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: comparison between low and high/low power lasers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Interventions for treating oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Practical modalities for prevention of fungal infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Oral and intestinal mucositis — causes and possible treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A systematic review of oral assessment instruments: what can we recommend to practitioners in children's and young people's cancer care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

A survey of current practice with regard to oral care for children being treated for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Homeopathic medicines for adverse effects of cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prevention of chemotherapy and radiation toxicity with glutamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Treatment-induced mucositis: an old problem with new remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Pharmacological interventions for preventing salivary gland dysfunction following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Cancer therapy and oral mucositis. An appraisal of drug prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Radiation induced mucositis: co-ordinating a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Interventions for treating oral mucositis for patients with cancer receiving treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

High-dose therapy with combined 5-fluorouracil and folinic acid with and without amifostine in the treatment of patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Topical application of honey in the management of radiation mucositis: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Mucositis prevention by improved dental care in acute leukemia patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Efficacy of He-Ne Laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Mouth care for nasopharyngeal cancer patients undergoing radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral mucositis in morning vs. evening irradiated patients: a randomised prospective study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase I trial of edatrexate in advanced breast and other cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, ran

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Administration of Ratanhia-based herbal oral care products for the prophylaxis of oral mucositis in cancer chemotherapy patients: a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Protection from Radiation-Induced Oral Mucositis by Misoprostol, a Prostaglandin E(1) Analog: A Placebo-Controlled, Double-Blind Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Radiation mucositis: a new approach to prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Antifungal prophylaxis during neutropenia and immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Efficacy of a spray compound containing a pool of collagen precursor synthetic aminoacids (l-proline, l-leucine, l-lysine and glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis: preliminary data of an open

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Oral ftorafur versus intravenous 5-fluorouracil. A comparative study in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomized, double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021

Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB4

7 January 2021